Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss (NCT06734273)
🩺 Plain-English Summary (8th-Grade Level)
This study examines whether adding tirzepatide-a medication that helps with weight loss-after sleeve gastrectomy surgery can help people lose more weight after the surgery; better improve conditions like Type 2 diabetes, high blood pressure, high cholesterol, and sleep apnea after surgery and; whether this causes more complications or side effects compared to surgery alone.
Who can join: Review the eligibility criteria below.
Location: Rush University Medical Center — Chicago, Illinois
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Rush University Medical Center — Chicago, Illinois
📞 Contact the Study Coordinator
Phone: (312) 942-5500
Email: anna_t_alecci@rush.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity and Obesity-related Medical Conditions
- Bariatric Surgery vs. Semaglutide vs. Tirzepatide — Cleveland, Ohio
- "F!reF!ghterF!t": Lifestyle Coaching Interventions for Obese Firefighters (FireFit) — Sommerville, Massachusetts
- Transition to Ambulatory Bariatric Surgery (TABS) Trial — Nashville, Tennessee
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD) — Columbia, Missouri
- 2024 Tirzepatide-Bariatric Surgery — Lexington, Kentucky
- Egg Intake, Metabolic Outcomes and Choline Levels — Québec, Quebec
Explore by condition: All Obesity and Obesity-related Medical Conditions clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.